Stay updated on Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial page.

Latest updates to the Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check35 days agoChange DetectedVersion update to v3.1.0 accompanies removal of several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and no new substantive topics added.SummaryDifference0.3%

- Check50 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2; removal of the non-critical 'Back to Top' UI element. No changes to core content, pricing, stock, or time-slot information.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while also removing previous location references and specific drug classifications.SummaryDifference2%

- Check78 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial page.